Skip to main content

Feature article – Saltigo rides out the cycle

1st July 2024

Submitted by:

Andrew Warmington

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Chemspec Europe 2024 in Düsseldorf on 19-20 June was the first for the new CEO of Saltigo. Michael Schäfer had been with the parent company Lanxess since 2007, mostly in the Material Protection Products business unit, which he headed for ten years before moving to take over at Saltigo in February.

Saltigo is a strong bellwether for the agrochemical field as one of the largest suppliers to it. It has not been an easy time in agro of late. As Schäfer noted, the industry moves in cycles and the ‘up’ part of the latest cycle was prolonged for a year by COVID-19. As a result the correction that has followed has been tougher and more prolonged too.

“We have several things coming together right now,” he said. “The cycle is at the bottom, with the price of wheat and inventory matters throughout the value chain. A second element is the Chinese capacity build-up we have seen; they are far overinvested into some generic positions, which has driven down prices for some key generics we have never seen before. This combination is dragging on the correction time.”

Need for speed

However, Schäfer added, away from monthly results, the outlook is more positive. The agrochemical industry has a clear commitment to the European supplier base. As a result, “I feel I have all the cards on the table to be the winner in Europe.”

Saltigo, in his view, is one of the leaders in this field both in sustainability and having “the most diverse and flexible technology assets”. Moreover, many competitors, particularly those under private equity ownership, have reduced their in-house capabilities and increasingly value those that Saltigo can offer, in development as well as production, as customers drive towards complex products and speed.

One reason why speed is becoming more important, added Dr Christoph Schaffrath, head of marketing and sales, is that new products are coming under cost pressure earlier. “The quicker you can get products on the market the better. We have that speed because of the close proximity of almost all our assets in Leverkusen. This is the feedback we are getting from all of our innovator customers.”

Although the trend towards Asia and India in particular is likely to continue, Schäfer said, there are plenty of reasons why it might not in this time of geopolitical issues, supply chain disruptions and sustainability focus. “There are many things which are making people nervous about betting all their cards on Asia, including India. So if that trend gets more hits, we are doing even better.”

Opportunities outside agro

In addition, Schäfer stressed, it is not all about agro for Saltigo; there is a lot going on in the non-agro world too. “There are technology developments that need new chemistry in the market. The customers want technologically advanced suppliers, who can help them to get things rolling quickly. And they want European or US assets for that.”

Digitalisation is playing a key role too. Localising production and supply chains means that different materials are needed and Saltigo is seeing its pipelines are beginning to fill up with non-agro projects. For example its unique ability to scale up metathesis is widely recognised, Schaffrath said, “and people are coming to us because they need us”.

“People who need these new technologies are not looking for the cheapest option,” said Schäfer. “They are asking ‘How protected is it?’, ‘How fast is it?’, ‘Do I have somebody who can play the whole chemical game for me?’, ‘Is the supply chain secure?’ and ‘Is the knowledge transfer secure?’.” With a base in the heart of Germany, Saltigo is protected as well as anyone can be from geopolitical issues.

The other key aspect is sustainability. “You really need to have an in-depth understanding of it to reduce the carbon footprints of products in long synthesis chains by 90%,” Schaffrath said. “We have been approached by a number of companies from outside the agrochemical and pharmaceutical world to do this. It’s not just about the right raw materials, it’s about setting up the whole infrastructure to drive this down.”

Saltigo is good at this – and so is its mother company, Schäfer continued. “Lanxess has pushed sustainability extremely aggressively in its internal targets. It has taken the lead at pretty much all levels possible and has implemented a very strong competence level internally on how to make it happen in reality.”

“Lanxess is an excellent platform for sustainability at Saltigo because it is both a technical and an intellectual topic there. It has been a surprise to me personally. In my former world at Lanxess, there were sustainability experts here and there. In Saltigo, I find sustainability to be an element that is sunk deeply in chemistry and process technology.”

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it.

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington